UTMB
Drs. Niesel and Herzog Medical Discovery News - bridging the world of medical discovery and you...
HomeAbout UsRadio ShowsPodcastListener QuestionsRadio StationsContactsReliable LinksStudents
 

When Drugs Don't Work
mp3 | wma | wav

When Drugs Don't Work

Without the liver, most drugs would go through our bodies with little effect. The liver is able to metabolize, or break down, drugs and chemically alter them so that they become active, travel the bloodstream, and can eventually be excreted by the body.

But people with certain genetic variations lack the ability to metabolize some drugs, and could face life threatening complications if theyíre depending on the very drug their livers canít process.

The problem comes up in patients who get cardiac stents. Itís a metal mesh tube thatís inserted into a blocked artery to keep it open. A drawback is that, within months, scar tissue can re-block the artery.

In 2008, a new stent came out that slowly releases medication to prevent tissue growth. Yet the enormously popular stent carries a big risk: clot formation. The body responds to the bare metal as a foreign object and covers it with platelets, increasing the risk of a fatal heart attack or stroke.

Doctors prescribe blood thinners to help lower the risk; however a rather large percentage of people carry a genetic variation that does not metabolize the most commonly prescribed blood thinner, Plavix, which means the drug is rendered ineffective. Fifty percent of those of Asian descent, 30 percent of African, and 25 percent of European ancestry can carry this genetic variation.

Now, a company, Spartan Biosciences, has developed a bedside testing machine capable of detecting this gene. The gene encodes a liver enzyme belonging to a family of enzymes called P450 that is important in processing drugs. Of the eight known variants of this gene, seven encode inactive versions of the enzyme. The new machine can screen patients for this variant in about an hour. Spartan Biosciences is waiting regulatory approval and hopes to have it in hospitals by the end of the year.

 


For more information…

First Bedside Genetic Test Could Prevent Heart Complications
From MIT's TechnologyReview.com: "Canada's Spartan Bioscience has developed a near 'plug-and-play' genotyping device that allows nurses and others to quickly screen patients at the bedside, perhaps while they are undergoing the stent placement procedure."

Patient information: Heart stents and angioplasty (Beyond the Basics)
As the title suggests, this article tells you everything you ever wanted to know about angioplasty and stents.

Heart Disease
Fact sheet from the Centers for Disease Control (CDC) on heart disease.

 

 
 

home | about us | radio shows | podcast | listener questions | radio stations | contact us | links | students | disclaimer

©2006-2007 Drs. David Niesel and Norbert Herzog. All Rights Reserved.
The University of Texas Medical Branch. Please review our site policies.
Send mail to J. Junemann with questions or comments about this web site.